MedCity News October 31, 2024
For those who rely on these treatments, affordable medication access is a matter of health, freedom, and dignity, and their mechanisms and outcomes are non-partisan.
I frequently have conversations with my patients in their early sixties who are planning for retirement – an important part of which is transitioning from commercial insurance to Medicare. When making this switch, a common concern for my older patients is ensuring they can still access their medications to manage their rheumatological conditions comfortably and affordably.
Injectable biologic medications, like Enbrel, are a highly effective but expensive, life-changing treatment option for rheumatoid and psoriatic arthritis. However, many patients have often found these medications out of reach because of their high cost, and Medicare was...